Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation.

The endothelium, as the interface between blood and all tissues, plays a critical role in inflammation. Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid, highly abundant in plasma, that potently regulates endothelial responses through interaction with its receptors (S1PRs). Here, we studied the role of S1PR2 in the regulation of the proadhesion and proinflammatory phenotype of the endothelium. By using genetic approaches and a S1PR2-specific antagonist (JTE013), we found that S1PR2 plays a key role in the permeability and inflammatory responses of the vascular endothelium during endotoxemia. Experiments with bone marrow chimeras (S1pr2(+/+) → S1pr2(+/+), S1pr2(+/+) → S1pr2(-/-), and S1pr2(-/-) → S1pr2(+/+)) indicate the critical role of S1PR2 in the stromal compartment, in the regulation of vascular permeability and vascular inflammation. In vitro, JTE013 potently inhibited tumor necrosis factor α-induced endothelial inflammation. Finally, we provide detailed mechanisms on the downstream signaling of S1PR2 in vascular inflammation that include the activation of the stress-activated protein kinase pathway that, together with the Rho-kinase nuclear factor kappa B pathway (NF-kB), are required for S1PR2-mediated endothelial inflammatory responses. Taken together, our data indicate that S1PR2 is a key regulator of the proinflammatory phenotype of the endothelium and identify S1PR2 as a novel therapeutic target for vascular disorders.

[1]  Masaru Ishii,et al.  The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. , 2012, The Journal of clinical investigation.

[2]  Roger J. Davis,et al.  Regulation of the immune response by stress‐activated protein kinases , 2009, Immunological reviews.

[3]  A. Malik,et al.  Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells , 2008, Circulation research.

[4]  J. Gamble,et al.  Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. , 2008, Blood.

[5]  H. Bonkovsky,et al.  Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate , 2008, Circulation research.

[6]  R. Proia,et al.  Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. , 2007, The Journal of clinical investigation.

[7]  U. Berg,et al.  Long-term renal function following bone marrow transplantation , 2007, Bone Marrow Transplantation.

[8]  T. Hla,et al.  Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[9]  J. Cyster,et al.  Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.

[10]  R. Proia,et al.  Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice* , 2007, Journal of Biological Chemistry.

[11]  Michael D. Davis,et al.  Synthesis and biological evaluation of γ-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists , 2007 .

[12]  Marian L Miller,et al.  The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function , 2006, Hearing Research.

[13]  K. Ley,et al.  Sphingosine-1 Phosphate Prevents Monocyte/Endothelial Interactions in Type 1 Diabetic NOD Mice Through Activation of the S1P1 Receptor , 2006, Circulation research.

[14]  J. Stypmann,et al.  High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor , 2006, Circulation.

[15]  Ian Parker,et al.  Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo , 2006, Nature chemical biology.

[16]  R. Proia,et al.  Essential Role for Sphingosine Kinases in Neural and Vascular Development , 2005, Molecular and Cellular Biology.

[17]  Lois E. H. Smith,et al.  Quantitative multi-gene transcriptional profiling using real-time PCR with a master template. , 2005, Experimental and molecular pathology.

[18]  J. Liao,et al.  Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells , 2005, Circulation.

[19]  Dianqing Wu,et al.  PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Nishida,et al.  Gα12/13- and Reactive Oxygen Species-dependent Activation of c-Jun NH2-terminal Kinase and p38 Mitogen-activated Protein Kinase by Angiotensin Receptor Stimulation in Rat Neonatal Cardiomyocytes* , 2005, Journal of Biological Chemistry.

[21]  A. Malik,et al.  RhoA/Rho-Associated Kinase Pathway Selectively Regulates Thrombin-Induced Intercellular Adhesion Molecule-1 Expression in Endothelial Cells via Activation of IκB Kinase β and Phosphorylation of RelA/p651 , 2004, The Journal of Immunology.

[22]  T. Hla,et al.  Structural and functional characteristics of S1P receptors , 2004, Journal of cellular biochemistry.

[23]  R. Proia,et al.  The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic Angiogenesis* , 2004, Journal of Biological Chemistry.

[24]  S. Narumiya,et al.  The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. , 2004, Molecular cell.

[25]  M. Simon,et al.  Thrombin Protease-activated Receptor-1 Signals through Gq- and G13-initiated MAPK Cascades Regulating c-Jun Expression to Induce Cell Transformation* , 2003, Journal of Biological Chemistry.

[26]  K. Claffey,et al.  Phosphorylation and Action of the Immunomodulator FTY720 Inhibits Vascular Endothelial Cell Growth Factor-induced Vascular Permeability* , 2003, Journal of Biological Chemistry.

[27]  J. Boehm,et al.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.

[28]  W. Aird The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. , 2003, Blood.

[29]  T. Ohmori,et al.  Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. , 2002, Biochemical and biophysical research communications.

[30]  Michael D. Davis,et al.  The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.

[31]  M. Brownlee Insight Review Articles , 2022 .

[32]  Junsuke Igarashi,et al.  Sphingosine 1-Phosphate and Isoform-specific Activation of Phosphoinositide 3-Kinase β , 2001, The Journal of Biological Chemistry.

[33]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[34]  K. Claffey,et al.  Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate , 1999, Cell.

[35]  C. H. Liu,et al.  Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. , 1999, Molecular biology of the cell.

[36]  J. Gamble,et al.  Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  U. Laufs,et al.  Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase* , 1998, The Journal of Biological Chemistry.

[38]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[39]  C. H. Liu,et al.  Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.

[40]  Y. Igarashi,et al.  Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. , 1997, Journal of biochemistry.

[41]  Kozo Kaibuchi,et al.  Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.

[42]  P. Carmeliet,et al.  Tissue factor expression during human and mouse development. , 1996, The American journal of pathology.

[43]  N. Mackman,et al.  Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. , 1993, The American journal of pathology.

[44]  M. Edidin,et al.  A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells. , 1990, Journal of immunology.

[45]  D. Sibley,et al.  Regulation of transmembrane signaling by receptor phosphorylation , 1987, Cell.

[46]  C. Feistritzer,et al.  Signal Transduction (1930 articles) , 2001 .

[47]  M. Maceyka,et al.  Sphingosine kinases: a novel family of lipid kinases. , 2002, Progress in nucleic acid research and molecular biology.

[48]  T. Michel,et al.  Sphingosine 1-Phosphate and Isoform-specific Activation of Phosphoinositide 3-Kinase (cid:1) EVIDENCE FOR DIVERGENCE AND CONVERGENCE OF RECEPTOR-REGULATED ENDOTHELIAL NITRIC-OXIDE SYNTHASE SIGNALING PATHWAYS* , 2001 .

[49]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[50]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .